Key terms
About CLLS
Cellectis SA operates as a clinical stage biotechnological company, which engages in gene-editing platform to develop cell and gene therapies. The company was founded by David J. Sourdive and André Choulika on February 20, 1999 and is headquartered in Paris, France.
Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
52-week range
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date
Key terms
Ad Feedback
Smart score
Latest CLLS news
Jan 13
8:09am ET
Cellectis SA: A Hold Rating Amidst Strategic Partnerships and Pipeline Potential
Nov 07
12:31pm ET
Analysts Offer Insights on Healthcare Companies: Cellectis SA (CLLS), Agenus (AGEN) and OrthoPediatrics (KIDS)
Nov 06
2:30am ET
Wall Street Analysts Are Bullish on Top Healthcare Picks
Nov 01
12:40pm ET
Wall Street Analysts Are Bullish on Top Healthcare Picks
Oct 27
3:50am ET
Analysts Are Bullish on These Healthcare Stocks: Terns Pharmaceuticals (TERN), Syndax Pharmaceuticals (SNDX)
No recent news articles are available for CLLS
No recent press releases are available for CLLS
CLLS Financials
Key terms
Ad Feedback
CLLS Forecasts
analyst rating
- buy
- hold
- sell
1-year stock price forecast
CLLS Competitors
$ Market cap
P/E ratio
$ Price
1d change
52-week range